meta-analysis | Q815382 |
scholarly article | Q13442814 |
P819 | ADS bibcode | 2015PLoSO..1018872Q |
P356 | DOI | 10.1371/JOURNAL.PONE.0118872 |
P932 | PMC publication ID | 4357383 |
P698 | PubMed publication ID | 25764442 |
P5875 | ResearchGate publication ID | 273912805 |
P2093 | author name string | Jing Yu | |
Man Li | |||
Na Li | |||
Chen Song | |||
Zhe Yu | |||
Jing-Jing Qiao | |||
P2860 | cites work | Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease | Q22337234 |
Comparison of two methods to detect publication bias in meta-analysis | Q29617904 | ||
Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. | Q33235606 | ||
Multivariate random effects meta-analysis of diagnostic tests with multiple thresholds | Q33515692 | ||
Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study | Q34613673 | ||
New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice. | Q36701684 | ||
Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer | Q37023236 | ||
Impact of screening test performance and cost on mortality reduction and cost-effectiveness of multimodal ovarian cancer screening | Q37059558 | ||
New potential and applications of contrast-enhanced ultrasound of the breast: Own investigations and review of the literature | Q37314564 | ||
Angiogenesis, vasculogenesis, and vasculogenic mimicry in ovarian cancer | Q37513086 | ||
Contrast-enhanced ultrasound: what is the evidence and what are the obstacles? | Q37525915 | ||
Novel contrast-enhanced ultrasound imaging in prostate cancer | Q38656611 | ||
Contrast imaging ultrasound detects abnormalities in the marmoset ovary | Q39569667 | ||
Can contrast-enhanced sonography distinguish benign from malignant breast masses? | Q39919022 | ||
Targeting an ultrasound contrast agent to folate receptors on ovarian cancer cells: feasibility research for ultrasonic molecular imaging of tumor cells | Q43106736 | ||
Diagnostic parameters to differentiate benign from malignant ovarian masses with contrast-enhanced transvaginal sonography | Q43271805 | ||
Prognostic value of pre-treatment DCE-MRI parameters in predicting disease free and overall survival for breast cancer patients undergoing neoadjuvant chemotherapy | Q44599093 | ||
Contrast-enhanced transvaginal sonography of benign versus malignant ovarian masses: preliminary findings | Q46520511 | ||
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). | Q51129805 | ||
Assessment of tissue perfusion by contrast-enhanced ultrasound | Q51650477 | ||
Disseminated tumor cells in bone marrow may affect prognosis of patients with gynecologic malignancies. | Q51821584 | ||
[Value of color Doppler ultrasonography, contrast-enhanced ultrasound and serum CA-125 detection in differential diagnosis of ovarian masses]. | Q53327247 | ||
Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study. | Q53424963 | ||
Contrast-enhanced ultrasonography of peripheral soft-tissue tumors: Feasibility study and preliminary results. | Q53677186 | ||
Contrast-enhanced ultrasound vs multidetector-computed tomography for detecting liver metastases in colorectal cancer: a prospective, blinded, patient-by-patient analysis | Q57778635 | ||
Ovarian Cancer | Q63966715 | ||
HEGESMA: genome search meta-analysis and heterogeneity testing | Q81849916 | ||
Ultrasound microbubble contrast and current clinical applications | Q83166866 | ||
Impact of combination chemotherapy with itraconazole on survival of patients with refractory ovarian cancer | Q95352432 | ||
[Diagnostic value of contrast-enhanced ultrasonography in ovarian tumors] | Q95393094 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e0118872 | |
P577 | publication date | 2015-03-12 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Contrast-enhanced ultrasonography in differential diagnosis of benign and malignant ovarian tumors | |
P478 | volume | 10 |
Q90339244 | A preliminary study: The sequential use of the risk malignancy index and contrast-enhanced ultrasonography in differential diagnosis of adnexal masses |
Q64104351 | Ability of F-FDG PET/CT Radiomic Features to Distinguish Breast Carcinoma from Breast Lymphoma |
Q89736413 | Application Value of Color Doppler Ultrasound and Ultrasound Contrast in the Differential Diagnosis of Ovarian tumor |
Q41223900 | Clinical value of combining transvaginal contrast-enhanced ultrasonography with serum human epididymisprotein-4 and the resistance index for early-stage epithelial ovarian cancer |
Q55452489 | Combination of serum CA19-9 and CA125 levels and contrast-enhanced ultrasound parametric data facilitates to differentiate ovarian serous carcinoma from ovarian malignant epithelial cancer. |
Q41337070 | Diagnostic accuracy of contrast-enhanced ultrasound for characterization of kidney lesions in patients with and without chronic kidney disease |